FDA has added a warning to Johnson & Johnson’s Covid-19 vaccine fact sheet after receiving preliminary reports of patients developing the rare neurological condition Guillain-Barré syndrome after receiving the shot, the agency said Monday.
One hundred suspected cases of GBS — among the 12.8 million people who have gotten the J&J shot — have been identified in the federal government’s database for adverse side effects after vaccination, FDA and CDC said. Of those, 95 were serious enough to require hospitalization, and one person died, FDA said.
“Although the available evidence suggests an association between the Janssen vaccine and increased risk of GBS, it is insufficient to establish a causal relationship,” FDA said.
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- ‘No other way to spin it’: CNN expert says inflation number ‘positive news’ - December 18, 2025
- Fairfax County freed illegal despite ICE request — now a man is dead - December 18, 2025
- US may be entering moderate moment as voters reject radicalism, poll suggests - December 18, 2025
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.
BPR INSIDER COMMENTS
Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!
